{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:02:54Z","timestamp":1791644574242,"version":"4.3.4"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1097\/iio.0b013e31822d6af1","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T21:36:52Z","timestamp":1317764212000},"page":"43-52","source":"Crossref","is-referenced-by-count":18,"title":["Current Evidence for Topical Azithromycin 1% Ophthalmic Solution in the Treatment of Blepharitis and Blepharitis-Associated Ocular Dryness"],"prefix":"10.1097","volume":"51","author":[{"given":"Peter","family":"Veldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Colby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-7-20210126","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0002-9394(14)72383-9","article-title":"Role of cell-mediated immunity to staphylococci in blepharitis.","volume":"111","author":"Ficker","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"R3-7-20210126","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000315024","article-title":"The lid margin is an underestimated structure for preservation of ocular surface health and development of dry eye disease.","volume":"45","author":"Knop","year":"2010","journal-title":"Dev Ophthalmol"},{"issue":"Pt 4","key":"R4-7-20210126","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/eye.1991.65","article-title":"Meibomian gland disease: classification and grading of lid changes.","volume":"5","author":"Bron","year":"1991","journal-title":"Eye (Lond)"},{"key":"R5-7-20210126","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-1-4615-5359-5_45","article-title":"Meibomian secretions in chronic blepharitis.","volume":"438","author":"McCulley","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"R6-7-20210126","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/archopht.1995.01100100054027","article-title":"Ocular surface changes and discomfort in patients with meibomian gland dysfunction.","volume":"113","author":"Shimazaki","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"R7-7-20210126","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0161-6420(82)34669-2","article-title":"Classification of chronic blepharitis.","volume":"89","author":"McCulley","year":"1982","journal-title":"Ophthalmology"},{"key":"R8-7-20210126","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/bjo.68.8.524","article-title":"Comparative bacteriology of chronic blepharitis.","volume":"68","author":"Dougherty","year":"1984","journal-title":"Br J Ophthalmol"},{"key":"R9-7-20210126","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00003226-199110010-00010","article-title":"Lid flora in blepharitis.","volume":"10","author":"Groden","year":"1991","journal-title":"Cornea"},{"key":"R10-7-20210126","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cell.2006.04.001","article-title":"Bacterially speaking.","volume":"125","author":"Bassler","year":"2006","journal-title":"Cell"},{"key":"R11-7-20210126","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004397-198702710-00005","article-title":"Chronic blepharitis and dry eyes.","volume":"27","author":"Bowman","year":"1987","journal-title":"Int Ophthalmol Clin"},{"key":"R12-7-20210126","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/35021228","article-title":"Toll-like receptors in the induction of the innate immune response.","volume":"406","author":"Aderem","year":"2000","journal-title":"Nature"},{"key":"R13-7-20210126","first-page":"2867","article-title":"The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells.","volume":"42","author":"Song","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-7-20210126","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1167\/iovs.07-0588","article-title":"Ocular pathogen or commensal: a PCR-based study of surface bacterial flora in normal and dry eyes.","volume":"48","author":"Graham","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R15-7-20210126","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/archopht.1984.01040030434019","article-title":"Association of rosacea and keratoconjunctivitis sicca.","volume":"102","author":"Lemp","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"R16-7-20210126","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00003226-199801000-00007","article-title":"Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation.","volume":"17","author":"Pflugfelder","year":"1998","journal-title":"Cornea"},{"key":"R17-7-20210126","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1542-0124(12)70150-7","article-title":"The contribution of meibomian disease to dry eye.","volume":"2","author":"Bron","year":"2004","journal-title":"Ocul Surf"},{"key":"R18-7-20210126","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archopht.116.7.849","article-title":"Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality.","volume":"116","author":"Shine","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"R20-7-20210126","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00006324-199701000-00014","article-title":"Importance of the lipid layer in human tear film stability and evaporation.","volume":"74","author":"Craig","year":"1997","journal-title":"Optom Vis Sci"},{"key":"R23-7-20210126","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0022-3565(24)35272-3","article-title":"Anti-inflammatory activity of macrolide antibiotics.","volume":"292","author":"Ianaro","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"R24-7-20210126","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/01.ico.0000214802.40313.fa","article-title":"Dysfunctional tear syndrome: a Delphi approach to treatment recommendations.","volume":"25","author":"Behrens","year":"2006","journal-title":"Cornea"},{"key":"R27-7-20210126","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1128\/AAC.31.12.1939","article-title":"Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms.","volume":"31","author":"Retsema","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"R28-7-20210126","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.clinthera.2008.10.020","article-title":"Conjunctival tissue pharmacokinetic properties of topical azithromycin 1 and moxifloxacin 0.5 ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.","volume":"30","author":"Torkildsen","year":"2008","journal-title":"Clin Ther"},{"key":"R29-7-20210126","first-page":"3","article-title":"Clinical development of 1 azithromycin in DuraSite, a topical azalide anti-infective for ocular surface therapy.","volume":"1","author":"Friedlaender","year":"2007","journal-title":"Clin Ophthalmol"},{"key":"R30-7-20210126","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1164\/rccm.200601-071OC","article-title":"Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome.","volume":"174","author":"Verleden","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R32-7-20210126","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1203\/PDR.0b013e318142582d","article-title":"Azithromycin suppresses activation of nuclear factor-kappa B and synthesis of pro-inflammatory cytokines in tracheal aspirate cells from premature infants.","volume":"62","author":"Aghai","year":"2007","journal-title":"Pediatr Res"},{"key":"R33-7-20210126","first-page":"2525","article-title":"Effect of Topical Azithromycin on Corneal Innate Immune Response.","volume":"52","author":"Sadrai","year":"2011","journal-title":"IOVS"},{"key":"R34-7-20210126","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/ICO.0b013e3181ca38a0","article-title":"Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1 on the signs and symptoms of subjects with blepharitis.","volume":"29","author":"Haque","year":"2010","journal-title":"Cornea"},{"key":"R36-7-20210126","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s12325-008-0096-9","article-title":"Efficacy of topical azithromycin ophthalmic solution 1 in the treatment of posterior blepharitis.","volume":"25","author":"Luchs","year":"2008","journal-title":"Adv Ther"}],"container-title":["International Ophthalmology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IIO.0b013e31822d6af1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T12:44:32Z","timestamp":1741783472000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004397-201105140-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/iio.0b013e31822d6af1","relation":{},"ISSN":["0020-8167"],"issn-type":[{"value":"0020-8167","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}